		Technical Data
S9500-03H	Synuclein, alpha (SNCA, Alpha Synuclein, MGC110988, Non-A beta Component of AD Amyloid, Non-A4 Component of Amyloid Precursor, NACP, PARK1, PARK4, Parkinson Disease Familial 1, PD1)

Description:
Alpha synuclein is an abundant 140 amino acid neuronal protein, expressed primarily at presynaptic terminals in the central nervous system. Alpha synuclein has been associated with several neurodegenerative diseases. A point mutation in the gene coding for the alpha-synuclein protein was the first discovery linking this protein to a rare familial form of Parkinson's disease (PD). Subsequently, other mutations in the alpha-synuclein gene have been identified in familial PD. The aggregated proteinaceous inclusions called Lewy bodies found in PD and cortical Lewy body dementia (LBD) were discovered to be predominantly alpha-synuclein. Aberrant aggregation of alpha-synuclein has been detected in an increasing number of neurodegenerative diseases, collectively known as synucleopathies. Alpha-synuclein exists physiologically in both soluble and membrane-bound states, in unstructured and alpha-helical conformations, respectively. The physiological function of alpha-synuclein appears to require its translocation between these subcellular compartments and interconversion between the 2 conformations. Abnormal processing of alpha-synuclein is predicted to lead to pathological changes in its binding properties and function.

Applications:
Suitable for use in Immunohistochemistry. Other applications have not been tested.

Recommended Dilution:
Immunohistochemistry: 1:1000-1:2000
Optimal dilutions to be determined by the researcher.

Storage and Stability:
Lyophilized powder may be stored at -20°C. Stable for 12 months at -20°C. Reconstitute with sterile ddH2O. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Reconstituted product is stable for 12 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.

Type	Isotype	Clone	Grade
Pab	IgG		Serum

Size		Storage	Shipping	Source	Host
100ul		-20°C	Blue Ice	Human	Sheep

Concentration:

Not determined.

Immunogen:

A synthetic peptide correspondingto aa116-131, CMPVDPDNEAYEMPSEE of human alpha synuclein (KLH).

Purity:

Serum

Form

Supplied as a lyophilized powder. Reconstitute in 100ul of sterile ddH2O. Centrifuge to remove any insoluble material.

Specificity:

Recognizes human alpha-synuclein. Species Crossreactivity: Rat, mouse.

Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.

1. Lundvig, et al Brain Res Mol Brain Res 134, 3-17 (Mar 24, 2005). 2. Bennett, Pharmacol Ther 105, 311-31 (Mar, 2005). 3. Vekrellis, et al., Mol Neurobiol 30, 1-21 (Aug, 2004). 4. Martin, et al., Protein Pept Lett 11, 229-37 (Jun, 2004). 5. Doherty, et al., Acta Neuropathol (Berl) 107, 169-75 (Feb, 2004). 6. Goedert, Curr Opin Genet Dev 11, 343-51 (Jun, 2001). 7. Saito, et al., J Neurol Sci 177, 48-59 (Aug 1, 2000). 8. Lucking, et al., Cell Mol Life Sci 57, 1894-908 (Dec, 2000). 9. Kahle, et al., Ann N Y Acad Sci 920, 33-41 (2000). 10. Clayton, et al., Trends Neurosci 21, 249-54 (Jun, 1998).